Medpace Holdings (MEDP) Equity Average (2016 - 2026)

Medpace Holdings has reported Equity Average for 11 years, with the latest figure at $528.7 million in Q1 2026.

• For the quarter ending Q1 2026, Equity Average fell 25.49% year-over-year to $528.7 million; the trailing twelve-month figure through Mar 2026 stood at $528.7 million (down 25.49% YoY), and the FY2025 full-year result was $642.3 million, down 7.21% from the prior year.
• Equity Average for Q1 2026 stood at $528.7 million, up from $376.4 million in the prior quarter.
• The five-year high for Equity Average was $853.5 million in Q4 2024, with the low at $233.0 million in Q3 2025.
• Historically, Equity Average has averaged $519.4 million across 5 years, with a median of $444.1 million in 2022.
• Annual changes were most pronounced in 2024 — Equity Average jumped 94.38% — and 2025, when it tumbled 71.67%.
• Medpace Holdings' Equity Average stood at $368.1 million in 2022, then soared by 39.88% to $514.9 million in 2023, then jumped by 65.75% to $853.5 million in 2024, then tumbled by 55.9% to $376.4 million in 2025, then jumped by 40.48% to $528.7 million in 2026.
• The last three Equity Average figures came in at $528.7 million (Q1 2026), $376.4 million (Q4 2025), and $233.0 million (Q3 2025), per Business Quant data.